MULTIPLE TRAUMA STRUCTURING IN CHILDREN WITH ESTIMATION ACCORDING TO ISS SYSTEM AND CONCENTRATIONS OF S100B PROTEIN MARKERS AND CYSTATIN C

Cover Page


Cite item

Abstract

Introduction: to analyze pathological processes in a patient with multiple trauma. Classification and structuring are not taken into account, as they require estimation of condition severity and dynamics of pathological process. It is frequently impossible to do so. In every specific case, it is necessary to structure multiple trauma. The Injury Severity Score (ISS) system is useful in this case, as it consists of a combination, certain quantitative and qualitative estimate which makes it possible to estimate a patient’s condition at early pre-hospital stage and adjust treatment. Purpose: to make a structural analysis of a multiple trauma in children in the state of shock using ISS and concentrations of S100B protein and cystatin C to change the examination tactics and improve treatment outcomes. Materials and methods. 44 patients in shock with multiple trauma were structured and examined. The patients came for treatment from cities of the northern region and the city of Kemerovo. Patients mainly had a predominant severe cranial cerebral injury (SCCI). There were 36 patients including two patients with diffuse axonal injuries and 8 patients with predominant skeletal trauma (ST) and damage of internal organs with the syndrome of intraperitoneal bleeding (SPB). Results: treatment protocols were taken into account alongside with objectively obtained data on multiple trauma structure based on the ISS severity scale. We obtained reliable data on the type of changes in S100B and cystatin C concentrations during the acute period of multiple trauma. Conclusions: multiple trauma structuring in children using the ISS system and S100B protein and cystatin C concentrations enables objective detection of signs characterizing the severity of an acute period among those injured and optimization of the examination scheme along with a treatment program.

About the authors

V. B. Bakowski

Regional Children’s Clinical Hospital; Voroshilova str., 21, Kemerovo

Author for correspondence.
Email: bakovskivb@rambler.ru
Cand. Sci. (Med.), doctor, Department of traumatology and orthopedics, Regional Children’s Clinical Hospital Russian Federation

D. G. Gibadyllin

Regional Children’s Clinical Hospital; Voroshilova str., 21, Kemerovo

Email: damirg55@mail.ru
head of the Department of traumatology and orthopedics, Regional Children’s Clinical Hospital Russian Federation

N. A. Shabaldin

Kemerovo State Medical University; Voroshilova str., 21, Kemerovo

Email: shabaldin.nk@yandex.ru
Cand. Sci. (Med.), assistant of the department of pediatric surgical diseases, Kemerovo State Medical University of the Ministry of health of Russia Russian Federation

S. I. Golovkin

Kemerovo State Medical University; Voroshilova str., 21, Kemerovo

Email: golovkins2@mail.ru
Dr. Sci. (Med.), associate professor of the department of pediatric surgical diseases, Kemerovo State Medical University of the Ministry of health of Russia Russian Federation

V. A. Utkin

Pyatigorsk State Research Institute of Balneotherapy

Email: orgotdel@gniik.ru
Dr. Sci (Med.), leading researcher of the Federal state institution Pyatigorsk State Research Institute of Balneotherapy Russian Federation

References

  1. Талыпов Э. А., Мячин М. Ю., Куксова А. С., Иоффе Ю. С., Кордонский А. Ю. Медикаментозная нейропротекция в остром периоде черепно-мозговой травмы средней степени тяжести. Медицинский Совет. 2015; (10):82–83. DOI: https://doi. org/10.21518/2079–701X-2015–10–82–92
  2. Peterson N., James L. Polytrauma in children. Orthopaedics and Trauma. 2018; 32 (5): 280–7. DOI: 10.1016/j. mporth.2018.07.004
  3. Пшениснов К. В., Александрович Ю. С., Миронов П. И., Суханов Ю. В., Кузьмин О. В., Блинов С. А., Кон-дин А. Н. Особенности инфузионной терапии у детей с тяжелой сочетанной травмой. Анестезиология и реаниматология. 2016;(1):28–32. doi: 10.18821/0201–7563–2016–61–1–28–32.
  4. Naqvi G., Johansson G., Yip G., Rehm A., Carrothers A., Stöhr K. Mechanisms, patterns and outcomes of paediatric polytrauma in a UK major trauma centre. Annals of the Royal College of Surgeons of England. 2017;99(1): 39–45. doi: 10.1308/rcsann.2016.0222.
  5. Тимофеев В. В., Бондаренко А. В. Структура и характер политравмы у детей в городе Барнауле. Травматология и ортопедия России. 2013;(2):94–98. DOI: org/10.21823/2311–2905–2013–2–94–98
  6. Karlbauer A., Woidke R. Оценка тяжести травмы: обзор наиболее часто используемых систем для оценки тяжести повреждений у травматологических больных. Вестник травматологии и ортопедии им. Н. Н. Приорова. 2003; (3): 16–19.
  7. Киреева Е. А. Изменения белкового метаболизма после скелетной травмы (обзор литературы). Гений ортопедии. 2013; (4): 109–113.
  8. Roumeliotis N., Dong C., Pettersen G., Crevier L., Emeriaud G. Hyperosmolar therapy in pediatric traumatic brain injury: a retrospective study. Child’s Nervous System. 2016; 32 (12): 2363–8. doi: 10.1007/s00381–016–3231-y
  9. Leetch A. N., Wilson B. Pediatric Major Head Injury: Not a Minor Problem. Emergency Medicine Clinics of North America. 2018;36(2):459–72. DOI: https://doi. org/10.1016/j. emc.2017.12.012
  10. Ганцева Х. Х., Габитова Д. М., Сулейманова Л. Т. Оценка состояния органов и систем больного на основе изменений в содержании маркерных аутоантител. Креативная хирургия и онкология. 2012;(3): 79–84. DOI: org/10.24060/2076–3093–2012–0–3–79–84
  11. Žurek J., Fedora M. The usefulness of S100B, NSE, GFAP, NF-H, secretagogin and Hsp70 as a predictive biomarker of outcome in children with traumatic brain injury. Acta neurochirurgica. 2012; 154(1): 93–103. doi: 10.1007/s00701– 011–1175–2
  12. Sandler S. J. I., Figaji A. A., Adelson P. D.: Clinical applications of biomarkers in pediatric traumatic brain injury. Child’s Nervous System. 2010;(26):205–13. doi: 10.1007/s00381–009–1009–1
  13. Morochovič R., Rácz O., Kitka M., Pingorová S., Cibur P., Tomková D., Lenártová R. Serum S100B protein in early management of patients after mild traumatic brain injury. European Journal of Neurology. 2009;(16):1112–7. DOI:10.11 11/j.1468–1331.2009.02653. x
  14. Пинелис В. Г., Сорокина Е. Г., Семенова Ж. Б., Карасева О. В., Мещеряков С. В., Чернышева Т. А., Арсеньева Е. Н., Рошаль Л. М. Биомаркеры повреждения мозга при черепно-мозговой травме у детей. Журнал неврологии и психиатрии им. С. С. Корсакова. 2015;115(8):66–72. doi: 10.17116/jnevro20151158166–72
  15. Pickering A., Carter J., Hanning I., Townend W. Emergency department measurement of urinary S100B in children following head injury: can extracranial injury confound findings? Emergency medical journals. 2008;(25):88–89. DOI: http://dx. doi. org/10.1136/emj.2007.046631
  16. Routsi C., Stamataki E., Nanas S., Psachoulia C., Stathopoulos A., Koroneos A., Zervou M., Jullien G., Roussos C. Increased levels of serum S100B protein in critically ill patients without brain injury. Shock. 2006;(26):20–4. doi: 10.1097/01. shk.0000209546.06801. d7
  17. Виллевальде С. В., Гудгалис Н. И., Кобалава Ж. Д. Цистатин С как новый маркер нарушения функции почек и сердечно-сосудистого риска. Кардиология. 2010;50(6): 78–82
  18. Bricon T. Le, Leblanc I., Benlakehal M. et al. Evaluation of renal function in intensive care: plasma cystatin C vs. creatinine and derived glomerular filtration rates. Clin Chem Lab Med. 2005; 43 (9): 953–7. doi: 10.1515/CCLM.2005.163
  19. Nazik A., Acıkgoz Y., Sukru Paksu1 M. Is Serum Cystatin C a Better Marker than Serum Creatinine for Monitoring Renal Function in Pediatric Intensive Care Unit?. J. Trop Pediatr. 2012; 58 (6): 429–34. DOI: org/10.1093/tropej/fms011
  20. Chen S., Shi J., Yibulayin X., Wu T., Yang X., Zhang J., Baiheti P. Cystatin C is a moderate predictor of acute kidney injury in the early stage of traumatic hemorrhagic shock. Experimental and Therapeutic Medicine. 2015;237–40. DOI: https://doi.org/10.3892/etm.2015.2446
  21. Lin Q., Mao J. Early prediction of acute kidney injury in children: known biomarkers but novel combination. World Journal of Pediatrics. 2018;14(6):617–20 doi: 10.1007/s12519–018–0180–4

Copyright (c) 2019 Bakowski V.B., Gibadyllin D.G., Shabaldin N.A., Golovkin S.I., Utkin V.A.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies